Hormone-induced aberrations in electromagnetic adhesion signaling as a developmental factor of androgenetic alopecia.

In androgenetic alopecia, overactivation of the androgen hormone cascade in genetically predisposed persons leads to miniaturization of the dermal papilla of the hair follicle and to reduction in the number of papilla cells in the scalp, but the mechanisms explaining this miniaturization have remained unclear. According to our hypothesis, the increase of dihydrotestosterone (DHT) production in the overactive androgen state inhibits cell mitosis in the dermal papilla and contributes to the induction of programmed cell death (apoptosis). Normally, DNA molecules have a negative charge, which doubles in every cell mitosis. In the catagen and telogen phases, the sulphur-rich hair moves upwards, dehydrates and develops an increasing positive charge. In a normal hair-growth cycle, the epithelial column shortens and the secondary germ is formed and it invaginates the dermal papilla by electromagnetic attraction. In the mitotic inhibition state induced by DHT, the negative charge decreases, leading to a weakening of the electromagnetic adhesion forces and weaker electrical attraction between the undifferentiated germ cells and the dermal papilla. Insulin resistance has an additional pathogenic role in the excessive miniaturization of the hair follicle. The vasoactive substances associated with endothelial dysfunction in insulin resistance induce microcirculatory disturbance, perifollicular vasoconstriction and stimulation of smooth muscle cell proliferation in the vascular wall. This leads to microvascular insufficiency and local tissue hypoxia and progressive miniaturization of hair follicles.

[1]  S. Keinänen-Kiukaanniemi,et al.  Early androgenetic alopecia as a marker of insulin resistance , 2000, The Lancet.

[2]  J. Manson,et al.  Male pattern baldness and coronary heart disease: the Physicians' Health Study. , 2000, Archives of internal medicine.

[3]  Cynthia Kenyon,et al.  Signals from the reproductive system regulate the lifespan of C. elegans , 1999, Nature.

[4]  Sandy Chang,et al.  Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice , 1999, Cell.

[5]  C. Jahoda Cellular and developmental aspects of androgenetic alopecia , 1998, Experimental dermatology.

[6]  Rodney D Sinclair Male pattern androgenetic alopecia , 1998, BMJ.

[7]  D. Whiting Male pattern hair loss: current understanding , 1998, International journal of dermatology.

[8]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[9]  S. Coppack,et al.  Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome , 1997, Diabetes.

[10]  S. L. Ringler,et al.  Transcutaneous Po2 of the Scalp in Male Pattern Baldness: A New Piece to the Puzzle , 1996, Plastic and reconstructive surgery.

[11]  W. Bergfeld Androgenetic alopecia: an autosomal dominant disorder. , 1995, The American journal of medicine.

[12]  S. Eto,et al.  Androgen receptors, 5 alpha-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  D A Whiting,et al.  Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. , 1993, Journal of the American Academy of Dermatology.

[14]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[15]  P. Klemp,et al.  Subcutaneous blood flow in early male pattern baldness. , 1989, The Journal of investigative dermatology.

[16]  H. Mcgill,et al.  Heart contains receptors for dihydrotestosterone but not testosterone: Possible role in the sex differential in coronary heart disease , 1989, The Anatomical record.

[17]  K. Adachi,et al.  The conversion of testosterone to 17 -hydroxy-5 -androstan-3-one (dihydrotestosterone) by human hair follicles. , 1972, The Journal of clinical endocrinology and metabolism.

[18]  S. Jones The floating Zepitos. , 1995, The American journal of medicine.